These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 30026443)

  • 1. [IV. Multiple Myeloma - Development of Novel Therapeutic Strategy].
    Chou T
    Gan To Kagaku Ryoho; 2018 May; 45(5):810-815. PubMed ID: 30026443
    [No Abstract]   [Full Text] [Related]  

  • 2. Proteasome inhibitors in the treatment of multiple myeloma.
    McBride A; Ryan PY
    Expert Rev Anticancer Ther; 2013 Mar; 13(3):339-58. PubMed ID: 23477520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Efficacy of novel agents for patients with newly diagnosed symptomatic multiple myeloma].
    Sunami K
    Rinsho Ketsueki; 2012 Jun; 53(6):580-6. PubMed ID: 22790632
    [No Abstract]   [Full Text] [Related]  

  • 4. Multiple myeloma: new options, new challenges.
    Lacy MQ
    Mayo Clin Proc; 2006 Jul; 81(7):877-9. PubMed ID: 16835966
    [No Abstract]   [Full Text] [Related]  

  • 5. Smoldering multiple myeloma: special considerations surrounding treatment on versus off clinical trials.
    Manasanch EE; Korde N; Mailankody S; Tageja N; Bhutani M; Roschewski M; Landgren O
    Haematologica; 2014 Dec; 99(12):1769-71. PubMed ID: 25472951
    [No Abstract]   [Full Text] [Related]  

  • 6. Emerging drugs in multiple myeloma.
    Ghobrial IM; Leleu X; Hatjiharissi E; Hideshima T; Mitsiades C; Schlossman R; Anderson KC; Richardson P
    Expert Opin Emerg Drugs; 2007 Mar; 12(1):155-63. PubMed ID: 17355220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New Treatments and Insights in Multiple Myeloma.
    Faiman B; Noonan K
    ONS Connect; 2016 Jun; 31(6):4 p following 31. PubMed ID: 27430103
    [No Abstract]   [Full Text] [Related]  

  • 8. New agents and approaches in the treatment of multiple myeloma.
    Anderson KC
    Clin Adv Hematol Oncol; 2003 Mar; 1(3):151-2. PubMed ID: 16224394
    [No Abstract]   [Full Text] [Related]  

  • 9. Update on proteasome inhibitors in multiple myeloma.
    Richardson PG
    Clin Adv Hematol Oncol; 2014 Mar; 12(3):179-81. PubMed ID: 24927266
    [No Abstract]   [Full Text] [Related]  

  • 10. [Therapeutic experiences in multiple myeloma].
    Sonntag R; Favre E; Martz G
    Schweiz Med Wochenschr; 1972 Nov; 102(44):1588-9. PubMed ID: 4566555
    [No Abstract]   [Full Text] [Related]  

  • 11. [Hematologic Malignancies/Pediatric Malignancies. III. Treatment of Relapsed/Refractory Multiple Myeloma].
    Murakami H; Saitoh T; Kasamatsu T
    Gan To Kagaku Ryoho; 2016 May; 43(5):539-44. PubMed ID: 27344682
    [No Abstract]   [Full Text] [Related]  

  • 12. Chemotherapy of multiple myeloma: melphalan--40 years old and still going strong.
    Bergsagel PL
    Biol Blood Marrow Transplant; 2003 Jan; 9(1):2-3. PubMed ID: 12533738
    [No Abstract]   [Full Text] [Related]  

  • 13. Novel agents and the paradigm of continuous treatment in multiple myeloma.
    Palumbo A
    Leuk Res; 2012 Nov; 36 Suppl 1():S1-2. PubMed ID: 23176718
    [No Abstract]   [Full Text] [Related]  

  • 14. Novel anticancer agents for multiple myeloma: a review of the evidence for their therapeutic and economic value.
    Gaultney JG; Redekop WK; Sonneveld P; Uyl-de Groot CA
    Expert Rev Anticancer Ther; 2012 Jun; 12(6):839-54. PubMed ID: 22716498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of effective new treatments for multiple myeloma.
    Anderson KC; Pazdur R; Farrell AT
    J Clin Oncol; 2005 Oct; 23(28):7207-11. PubMed ID: 16145064
    [No Abstract]   [Full Text] [Related]  

  • 16. [Proteasome inhibitors for multiple myeloma].
    Yano H; Iida S
    Nihon Rinsho; 2007 Jan; 65 Suppl 1():601-4. PubMed ID: 17476759
    [No Abstract]   [Full Text] [Related]  

  • 17. A strategic framework for novel drug development in multiple myeloma.
    Anderson KC; Hannah AL; Pazdur R; Farrell AT
    Br J Haematol; 2007 Jul; 138(2):153-9. PubMed ID: 17593022
    [No Abstract]   [Full Text] [Related]  

  • 18. Monoclonal antibodies in multiple myeloma: data from the 2015 ASH meeting.
    Lonial S
    Clin Adv Hematol Oncol; 2016 Feb; 14(2):82-4. PubMed ID: 27057804
    [No Abstract]   [Full Text] [Related]  

  • 19. Multiple myeloma therapies.
    Strobeck M
    Nat Rev Drug Discov; 2007 Mar; 6(3):181-2. PubMed ID: 17396289
    [No Abstract]   [Full Text] [Related]  

  • 20. Carfilzomib for the treatment of multiple myeloma.
    Lue J; Goel S; Mazumder A
    Drugs Today (Barc); 2013 Mar; 49(3):171-9. PubMed ID: 23527321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.